No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract MRCN-003/CCTGMYX.1: Weekly carfilzomib, cyclophosphamide, and dexamethasone may be a safe and effective option for patients with relapsed/refractory multiple myeloma

byKathleen Lau

March 19, 2021

in StudyGraphics

RELATED REPORTS

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

Pfizer’s Talzenna combo significantly delays prostate cancer progression

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Ketamine infusion significantly reduces depressive symptoms among adolescents with treatment-resistant depression

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

April 2, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 1, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Intrapartum serum prolactin may predict risk of postpartum diabetes

Chronic Disease

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

March 26, 2026

Large proportion of late preterm infants and older admitted to the NICU

2 Minute Medicine Rewind March 22, 2021

Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study

Early enteral feeding safe for neonates with congenital gastrointestinal malformation undergoing intestinal anasatmosis

#VisualAbstract: ChAdOx1-nCoV-19 vaccine maintains efficacy despite a longer prime-boost interval

#VisualAbstract: Short-course antimicrobial therapy effective for pediatric community-acquired pneumonia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result